Capital Impact Advisors, LLC Syros Pharmaceuticals, Inc. Transaction History

Capital Impact Advisors, LLC

  • $3.16 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 18, 2021
SELL
$7.19 - $14.95 $1.21 Million - $2.52 Million
-168,600 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$8.69 - $14.47 $1.47 Million - $2.44 Million
168,600 New
168,600 $1.49 Million

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $4.25M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email